1. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
   Jing Si et al, 2019, Cancer Medicine CrossRef
2. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast‐conserving therapy
   Nai‐si Huang et al, 2018, Cancer Medicine CrossRef
3. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion
   Sijia Han et al, 2021, Journal of Applied Clinical Medical Physics CrossRef
4. Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
   Claudia J. C. Meurs et al, 2023, Annals of Surgical Oncology CrossRef
5. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base
   Megan E. Miller et al, 2016, Annals of Surgical Oncology CrossRef
6. Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update
   Sheikh Zahoor et al, 2017, Journal of Breast Cancer CrossRef
7. Precise application of sentinel lymph node biopsy in patients with ductal carcinoma in situ: A systematic review and meta-analysis of real-world data
   Ching-Wen Chiu et al, 2022, Surgical Oncology CrossRef
8. Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
   Jing-Ming Ye et al, 2021, Chinese Medical Journal CrossRef